Implementing practical strategies can significantly improve your dosing consistency and reduce the likelihood of missed injections
While prevalence of type 1 diabetes is higher in first-degree relatives of people with type 1 diabetes (6% vs 0.4% in the general population), 85% of people diagnosed with type 1 diabetes do not have a first-degree relative with the disease
Retatrutide is the newest, triple-action option, targeting GLP-1, GIP, and glucagon for the strongest results in early studies
Second, monitor for nausea, vomiting, or appetite changes that extend beyond expected GLP-1 side effects
The office checks the denial reason usually one of a small set and either resubmits with the missing documentation or asks the patient to schedule a follow-up to gather what was missing the first time
However, we did see clear sustained differences in body weight, fat and plasma leptin, indicating the diet intervention was long enough to impact metabolic health